英菲格拉替尼很好吗？太原能买到吗？

Infigratinib is an antineoplastic drug that inhibits tumor growth in cholangiocarcinoma. Demonstrated antitumor activity in mouse and rat xenograft human tumor models with activating FGFR2 or FGFR3 alterations, such as FGFR2-TTC28 or FGFR2-TRA2B fusions. In clinical trials, the overall response rate for treated cholangiocarcinoma (CCA) patients was 23%, with some patients achieving complete responses, with response durations as long as 5.5 months, ranging from 0.03 to 28.3 months. Some cancer patients with FGFR mutations also show inherent resistance to infigratinib, resulting in negligible treatment efficacy. Research on the molecular pathways of resistance is ongoing. So, is infigratinib good? Can I buy it in Taiyuan?

Regarding this question, the editor can give you a clear answer. Sorry, Infigratinib is not currently on the market in China. Patients in Taiyuan cannot purchase it in domestic pharmacies and hospitals. The only way to purchase it is to purchase the drug overseas. Purchasing drugs overseas is relatively risky for inexperienced patients in China. Not only are they easily deceived due to language barriers, but the round-trip travel expenses plus the price of the drugs are also a huge expense. However, medication treatment is imminent, and patients have to "carry forward with heavy burdens." At this time, domestic and overseas medical service organizations (Medical Travel) can share the pressure for you. The Infigratinib purchased by Medical Travel can shorten the entire drug purchase time, allowing you to quickly use the drug in China. The entire drug purchase process is safe and convenient, and is more affordable than purchasing the medicine yourself. Action is worse than heartbeat. If you want to know more information, please contact the Medical Companion Brigade and we will answer your questions wholeheartedly.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.